San Francisco-based digital health startup Transcarent has secured $126 million in a series D funding round to speed up AI-powered advancements on its platform. As the company announced on Tuesday, May 2, 2024, the funding round was led by General Catalyst and 7wireVentures, and backed by new investors Memorial Hermann Health System and Geodesic Capital. Health tech startup secures Transcend secures additional $126 million in Series D funding round to accelerate AI capabilities. The company now values at $2.2 billion.
read more..